Global Plasma Protein Therapeutics Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Plasma Protein Therapeutics market size was valued at US$ 27460 million in 2023. With growing demand in downstream market, the Plasma Protein Therapeutics is forecast to a readjusted size of US$ 44250 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Plasma Protein Therapeutics market. Plasma Protein Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Protein Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Protein Therapeutics market.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Key Features:
The report on Plasma Protein Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Protein Therapeutics market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Protein Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Protein Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Protein Therapeutics industry. This include advancements in Plasma Protein Therapeutics technology, Plasma Protein Therapeutics new entrants, Plasma Protein Therapeutics new investment, and other innovations that are shaping the future of Plasma Protein Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Protein Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Protein Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Protein Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Protein Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Protein Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Protein Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Protein Therapeutics market.
Market Segmentation:
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Plasma Protein Therapeutics market?
What factors are driving Plasma Protein Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Protein Therapeutics market opportunities vary by end market size?
How does Plasma Protein Therapeutics break out type, application?
According to our LPI (LP Information) latest study, the global Plasma Protein Therapeutics market size was valued at US$ 27460 million in 2023. With growing demand in downstream market, the Plasma Protein Therapeutics is forecast to a readjusted size of US$ 44250 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Plasma Protein Therapeutics market. Plasma Protein Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Protein Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Protein Therapeutics market.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Key Features:
The report on Plasma Protein Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Protein Therapeutics market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Protein Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Protein Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Protein Therapeutics industry. This include advancements in Plasma Protein Therapeutics technology, Plasma Protein Therapeutics new entrants, Plasma Protein Therapeutics new investment, and other innovations that are shaping the future of Plasma Protein Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Protein Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Protein Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Protein Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Protein Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Protein Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Protein Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Protein Therapeutics market.
Market Segmentation:
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
- Hemophilia
- PID
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shire (Baxalta)
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Kamada
What is the 10-year outlook for the global Plasma Protein Therapeutics market?
What factors are driving Plasma Protein Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Protein Therapeutics market opportunities vary by end market size?
How does Plasma Protein Therapeutics break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Protein Therapeutics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Plasma Protein Therapeutics Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Plasma Protein Therapeutics Sales by Type
2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2019-2024)
2.4 Plasma Protein Therapeutics Segment by Application
2.4.1 Hemophilia
2.4.2 PID
2.4.3 Others
2.5 Plasma Protein Therapeutics Sales by Application
2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2019-2024)
3 GLOBAL PLASMA PROTEIN THERAPEUTICS BY COMPANY
3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2019-2024)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2019-2024)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
3.3 Global Plasma Protein Therapeutics Sale Price by Company
3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
3.4.2 Players Plasma Protein Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma Protein Therapeutics Sales Growth
4.4 APAC Plasma Protein Therapeutics Sales Growth
4.5 Europe Plasma Protein Therapeutics Sales Growth
4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Plasma Protein Therapeutics Sales by Country
5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2019-2024)
5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2019-2024)
5.2 Americas Plasma Protein Therapeutics Sales by Type
5.3 Americas Plasma Protein Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Protein Therapeutics Sales by Region
6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2019-2024)
6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2019-2024)
6.2 APAC Plasma Protein Therapeutics Sales by Type
6.3 APAC Plasma Protein Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Protein Therapeutics by Country
7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2019-2024)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2019-2024)
7.2 Europe Plasma Protein Therapeutics Sales by Type
7.3 Europe Plasma Protein Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Protein Therapeutics by Country
8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type
8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
10.4 Industry Chain Structure of Plasma Protein Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Protein Therapeutics Distributors
11.3 Plasma Protein Therapeutics Customer
12 WORLD FORECAST REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2025-2030)
12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Protein Therapeutics Forecast by Type
12.7 Global Plasma Protein Therapeutics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shire (Baxalta)
13.1.1 Shire (Baxalta) Company Information
13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shire (Baxalta) Main Business Overview
13.1.5 Shire (Baxalta) Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Protein Therapeutics Product Portfolios and Specifications
13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Protein Therapeutics Product Portfolios and Specifications
13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Kamada
13.12.1 Kamada Company Information
13.12.2 Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
13.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kamada Main Business Overview
13.12.5 Kamada Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Protein Therapeutics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Plasma Protein Therapeutics Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Plasma Protein Therapeutics Sales by Type
2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2019-2024)
2.4 Plasma Protein Therapeutics Segment by Application
2.4.1 Hemophilia
2.4.2 PID
2.4.3 Others
2.5 Plasma Protein Therapeutics Sales by Application
2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2019-2024)
3 GLOBAL PLASMA PROTEIN THERAPEUTICS BY COMPANY
3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2019-2024)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2019-2024)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
3.3 Global Plasma Protein Therapeutics Sale Price by Company
3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
3.4.2 Players Plasma Protein Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma Protein Therapeutics Sales Growth
4.4 APAC Plasma Protein Therapeutics Sales Growth
4.5 Europe Plasma Protein Therapeutics Sales Growth
4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Plasma Protein Therapeutics Sales by Country
5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2019-2024)
5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2019-2024)
5.2 Americas Plasma Protein Therapeutics Sales by Type
5.3 Americas Plasma Protein Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Protein Therapeutics Sales by Region
6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2019-2024)
6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2019-2024)
6.2 APAC Plasma Protein Therapeutics Sales by Type
6.3 APAC Plasma Protein Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Protein Therapeutics by Country
7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2019-2024)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2019-2024)
7.2 Europe Plasma Protein Therapeutics Sales by Type
7.3 Europe Plasma Protein Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Protein Therapeutics by Country
8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type
8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
10.4 Industry Chain Structure of Plasma Protein Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Protein Therapeutics Distributors
11.3 Plasma Protein Therapeutics Customer
12 WORLD FORECAST REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2025-2030)
12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Protein Therapeutics Forecast by Type
12.7 Global Plasma Protein Therapeutics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shire (Baxalta)
13.1.1 Shire (Baxalta) Company Information
13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shire (Baxalta) Main Business Overview
13.1.5 Shire (Baxalta) Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Protein Therapeutics Product Portfolios and Specifications
13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Protein Therapeutics Product Portfolios and Specifications
13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Kamada
13.12.1 Kamada Company Information
13.12.2 Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
13.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kamada Main Business Overview
13.12.5 Kamada Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2019-2024) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 40. Americas Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 42. APAC Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Protein Therapeutics Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 46. APAC Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 47. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 52. Europe Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 60. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 61. Key Industry Trends of Plasma Protein Therapeutics
Table 62. Plasma Protein Therapeutics Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Protein Therapeutics Distributors List
Table 65. Plasma Protein Therapeutics Customer List
Table 66. Global Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Protein Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Plasma Protein Therapeutics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Protein Therapeutics Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Plasma Protein Therapeutics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
Table 82. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Shire (Baxalta) Main Business
Table 84. Shire (Baxalta) Latest Developments
Table 85. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 87. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 92. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 97. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 102. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 107. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 112. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 117. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 122. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 127. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 132. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 136. Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
Table 137. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kamada Main Business
Table 139. Kamada Latest Developments
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2019-2024) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 40. Americas Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 42. APAC Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Protein Therapeutics Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 46. APAC Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 47. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 52. Europe Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 60. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 61. Key Industry Trends of Plasma Protein Therapeutics
Table 62. Plasma Protein Therapeutics Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Protein Therapeutics Distributors List
Table 65. Plasma Protein Therapeutics Customer List
Table 66. Global Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Protein Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Plasma Protein Therapeutics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Protein Therapeutics Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Plasma Protein Therapeutics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
Table 82. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Shire (Baxalta) Main Business
Table 84. Shire (Baxalta) Latest Developments
Table 85. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 87. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 92. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 97. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 102. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 107. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 112. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 117. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 122. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 127. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 132. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 136. Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
Table 137. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kamada Main Business
Table 139. Kamada Latest Developments
LIST OF FIGURES
Figure 1. Picture of Plasma Protein Therapeutics
Figure 2. Plasma Protein Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma Protein Therapeutics Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Coagulation Factor
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Albumin
Figure 12. Product Picture of Others
Figure 13. Global Plasma Protein Therapeutics Sales Market Share by Type in 2023
Figure 14. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Figure 15. Plasma Protein Therapeutics Consumed in Hemophilia
Figure 16. Global Plasma Protein Therapeutics Market: Hemophilia (2019-2024) & (K Units)
Figure 17. Plasma Protein Therapeutics Consumed in PID
Figure 18. Global Plasma Protein Therapeutics Market: PID (2019-2024) & (K Units)
Figure 19. Plasma Protein Therapeutics Consumed in Others
Figure 20. Global Plasma Protein Therapeutics Market: Others (2019-2024) & (K Units)
Figure 21. Global Plasma Protein Therapeutics Sales Market Share by Application (2023)
Figure 22. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2023
Figure 23. Plasma Protein Therapeutics Sales Market by Company in 2023 (K Units)
Figure 24. Global Plasma Protein Therapeutics Sales Market Share by Company in 2023
Figure 25. Plasma Protein Therapeutics Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2023
Figure 27. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 30. Americas Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 31. APAC Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 32. APAC Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 33. Europe Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 34. Europe Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 37. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 39. Americas Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 40. Americas Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 41. United States Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2023
Figure 46. APAC Plasma Protein Therapeutics Revenue Market Share by Regions in 2023
Figure 47. APAC Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 48. APAC Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 49. China Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 57. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 58. Europe Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 59. Europe Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 60. Germany Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 69. Egypt Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2023
Figure 75. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 76. Industry Chain Structure of Plasma Protein Therapeutics
Figure 77. Channels of Distribution
Figure 78. Global Plasma Protein Therapeutics Sales Market Forecast by Region (2025-2030)
Figure 79. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Plasma Protein Therapeutics
Figure 2. Plasma Protein Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma Protein Therapeutics Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Coagulation Factor
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Albumin
Figure 12. Product Picture of Others
Figure 13. Global Plasma Protein Therapeutics Sales Market Share by Type in 2023
Figure 14. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Figure 15. Plasma Protein Therapeutics Consumed in Hemophilia
Figure 16. Global Plasma Protein Therapeutics Market: Hemophilia (2019-2024) & (K Units)
Figure 17. Plasma Protein Therapeutics Consumed in PID
Figure 18. Global Plasma Protein Therapeutics Market: PID (2019-2024) & (K Units)
Figure 19. Plasma Protein Therapeutics Consumed in Others
Figure 20. Global Plasma Protein Therapeutics Market: Others (2019-2024) & (K Units)
Figure 21. Global Plasma Protein Therapeutics Sales Market Share by Application (2023)
Figure 22. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2023
Figure 23. Plasma Protein Therapeutics Sales Market by Company in 2023 (K Units)
Figure 24. Global Plasma Protein Therapeutics Sales Market Share by Company in 2023
Figure 25. Plasma Protein Therapeutics Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2023
Figure 27. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 30. Americas Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 31. APAC Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 32. APAC Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 33. Europe Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 34. Europe Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Plasma Protein Therapeutics Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Plasma Protein Therapeutics Revenue 2019-2024 ($ Millions)
Figure 37. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 39. Americas Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 40. Americas Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 41. United States Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2023
Figure 46. APAC Plasma Protein Therapeutics Revenue Market Share by Regions in 2023
Figure 47. APAC Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 48. APAC Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 49. China Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 57. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 58. Europe Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 59. Europe Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 60. Germany Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Figure 69. Egypt Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Plasma Protein Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2023
Figure 75. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 76. Industry Chain Structure of Plasma Protein Therapeutics
Figure 77. Channels of Distribution
Figure 78. Global Plasma Protein Therapeutics Sales Market Forecast by Region (2025-2030)
Figure 79. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2025-2030)
